Latest News

12345678910
Earnings Summary: EverQuote Q4benzinga.com
Via Benzinga · February 23, 2026
Hims & Hers Health’s (NYSE:HIMS) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Telehealth company Hims & Hers Health (NYSE:HIMS) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 28.4% year on year to $617.8 million. On the other hand, next quarter’s revenue guidance of $612.5 million was less impressive, coming in 5.6% below analysts’ estimates. Its GAAP profit of $0.08 per share was 92.5% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Capital One Slips As Private Credit Jitters Spreadbenzinga.com
Capital One Financial shares are trading lower Monday afternoon as a wave of selling hit U.S. bank and asset-management shares on worries about private credit and AI-exposed lending.
Via Benzinga · February 23, 2026
Everything You Need to Know About Musk’s ‘Self-Growing’ Moon City as He Races to ‘Secure the Future of Civilization’
SpaceX aims for “Starship cargo flights to the lunar surface for research, development, and exploratory missions” to start in 2028.
Via Barchart.com · February 23, 2026
Earnings Summary: JBT Marel Q4benzinga.com
Via Benzinga · February 23, 2026
10 Dividend Stocks For Perpetually Growing Retirement Incometalkmarkets.com
Via Talk Markets · February 23, 2026
Insights into Diversified Healthcare Q4 Earningsbenzinga.com
Via Benzinga · February 23, 2026
Myriad Genetics’s (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22%
Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales were flat year on year at $209.8 million. The company expects the full year’s revenue to be around $870 million, close to analysts’ estimates. Its non-GAAP profit of $0.04 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 23, 2026
IBM Stock Stung By New Anthropic Tool As Wall Street's AI Jitters Spreadinvestors.com
IBM stock sold off suddenly and sharply Monday as the tech giant became the latest victim to investor fears about Anthropic's AI code.
Via Investor's Business Daily · February 23, 2026
EverQuote (NASDAQ:EVER) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops 10%
Online insurance comparison site EverQuote (NASDAQ:EVER) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 32.5% year on year to $195.3 million. On the other hand, next quarter’s revenue guidance of $180 million was less impressive, coming in 7% below analysts’ estimates. Its GAAP profit of $1.54 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Earnings Summary: Atlas Energy Solutions Q4benzinga.com
Via Benzinga · February 23, 2026
Earnings Summary: Boise Cascade Q4benzinga.com
Via Benzinga · February 23, 2026
Primoris Services Q4 Earnings Report: What Investors Need to Knowbenzinga.com
Via Benzinga · February 23, 2026
This Very Special Income ETFs Has a 13% Yieldhttps://www.fool.ca/2026/02/23/this-very-special-income-etfs-has-a-13-yield/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=7a4b2a77-5d93-4fd1-a1e3-f623ff67f3b0
Global X Canadian Oil and Gas Equity Covered Call ETF (TSX:ENCC) is a covered call ETF income investors should know about.
Via The Motley Fool · February 23, 2026
2 Canadian ETFs to Buy and Hold in a TFSA Foreverhttps://www.fool.ca/2026/02/23/2-canadian-etfs-to-buy-and-hold-in-a-tfsa-forever-2/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=7b7325dd-46ce-4598-b8b8-7c8964351d17
Canadian REIT ETFs pay high but tax-inefficient yields, so a TFSA is the best place to hold them.
Via The Motley Fool · February 23, 2026
The Smartest Growth Stocks to Buy With $1,000 Right Nowfool.com
These two growth stocks are top buys.
Via The Motley Fool · February 23, 2026
American Express Hits Dow Jones On AI Doomsday 'Work Of Fiction'investors.com
American Express stock led the Dow Jones Industrial Average lower as markets gave credence to Citrini Research's 2027 AI recession scenario.
Via Investor's Business Daily · February 23, 2026
Bed Bath & Beyond: Q4 Earnings Insightsbenzinga.com
Via Benzinga · February 23, 2026
DMC Glb Q4 Earnings Report: What Investors Need to Knowbenzinga.com
Via Benzinga · February 23, 2026
SI-BONE Q4 Earnings Assessmentbenzinga.com
Via Benzinga · February 23, 2026
Paymentus (NYSE:PAY) Delivers Strong Q4 CY2025 Numbers But Stock Drops
Digital payment platform Paymentus (NYSE:PAY) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 28.1% year on year to $330.5 million. The company expects next quarter’s revenue to be around $335 million, coming in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.20 per share was 22.9% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
Why CrowdStrike Plunged For the Second Day In A Rowfool.com
AI disruption fears are leading to indiscriminate sell-offs in specific stocks.
Via The Motley Fool · February 23, 2026
Amazon’s $12B Investment In Louisiana Data Center Buildout To Create More Jobsstocktwits.com
The data center development across Caddo and Bossier Parishes will create 540 full-time jobs, the company said.
Via Stocktwits · February 23, 2026
Here's How Much $1000 Invested In Palo Alto Networks 10 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · February 23, 2026
BWX Technologies Earnings Review: Q4 Summarybenzinga.com
Via Benzinga · February 23, 2026
Earnings Breakdown: Backblaze Q4benzinga.com
Via Benzinga · February 23, 2026
SNDK: Is This The Cheapest Stock In All The AI Universe?talkmarkets.com
Via Talk Markets · February 23, 2026
Why Grail Shares Are Plummetingfool.com
A large clinical trial of the company's cancer screening test did not produce the desired result.
Via The Motley Fool · February 23, 2026
Skyward Specialty Insurance (NASDAQ:SKWD) Surprises With Q4 CY2025 Sales
Specialty insurance provider Skyward Specialty Insurance (NASDAQ:SKWD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 26.7% year on year to $385.6 million. Its non-GAAP profit of $1.17 per share was 14.9% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
JPMorgan Slides As Credit Fears Growbenzinga.com
JPMorgan Chase shares are sharply lower Monday afternoon, falling as investors dumped financials amid a broad sell-off tied to mounting worries over private credit and AI-linked credit risks.
Via Benzinga · February 23, 2026
Options Corner: Reignited Tariff Fears Facilitate A Contrarian Position In Super Micro Computerbenzinga.com
While Super Micro Computer got caught amid recent tariff-related anxieties, the smart money seems relatively confident about SMCI stock.
Via Benzinga · February 23, 2026
V2X Q4 Earnings Summary & Key Takeawaysbenzinga.com
Via Benzinga · February 23, 2026
Earnings Summary: BioMarin Pharmaceutical Q4benzinga.com
Via Benzinga · February 23, 2026
Insights into Addus HomeCare Q4 Earningsbenzinga.com
Via Benzinga · February 23, 2026
Earnings Breakdown: Innovex International Q4benzinga.com
Via Benzinga · February 23, 2026
AMC Entertainment’s (NYSE:AMC) Q4 CY2025 Sales Top Estimates
Theater company AMC Entertainment (NYSE:AMC) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $1.29 billion. Its non-GAAP loss of $0.18 per share was 28% above analysts’ consensus estimates.
Via StockStory · February 23, 2026
A 5.6% High-Yield Income ETF That You Can Take to the Bankhttps://www.fool.ca/2026/02/23/a-5-6-high-yield-income-etf-that-you-can-take-to-the-bank/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=228e6122-8bb0-4937-b6b5-e9943cce82e9
Here's why this high-quality ETF, offering a yield of 5.6%, is one of the best investments you can buy for passive income.
Via The Motley Fool · February 23, 2026
This 6% Dividend Stock Pays Cash Each and Every Monthhttps://www.fool.ca/2026/02/23/this-6-dividend-stock-pays-cash-each-and-every-month/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=5133746d-1178-42dc-b30e-f6ad4e1bcc43
This healthcare REIT’s monthly payout looks more supported than it was a year ago, but refinancing and leverage still matter.
Via The Motley Fool · February 23, 2026
Bitcoin Had a Rough Weekend. Here's What Drove the Near-5% Drop In the World's Largest Cryptocurrency.fool.com
A 5% drop in the crypto sector's most important token is a big deal.
Via The Motley Fool · February 23, 2026
Allison Transmission Q4 Earnings Assessmentbenzinga.com
Via Benzinga · February 23, 2026
Myriad Genetics Earnings Report: Q4 Overviewbenzinga.com
Via Benzinga · February 23, 2026
Claritev Q4 Earnings Summary & Key Takeawaysbenzinga.com
Via Benzinga · February 23, 2026
Summit Therapeutics: Q4 Earnings Insightsbenzinga.com
Via Benzinga · February 23, 2026
UFP Industries Q4 Earnings Report: What Investors Need to Knowbenzinga.com
Via Benzinga · February 23, 2026
Earnings Summary: Ultra Clean Hldgs Q4benzinga.com
Via Benzinga · February 23, 2026
Hims & Hers Health: Q4 Earnings Insightsbenzinga.com
Via Benzinga · February 23, 2026
Insights into ACV Auctions Q4 Earningsbenzinga.com
Via Benzinga · February 23, 2026
Something Rare Is Happening In Emerging Markets – And You Are Still Missing Itbenzinga.com
Emerging markets are outperforming U.S. stocks by 13 percentage points in two months — the biggest relative surge since 2008.
Via Benzinga · February 23, 2026
Keysight Techs Earnings Review: Q1 Summarybenzinga.com
Via Benzinga · February 23, 2026
Insights into Tarsus Pharmaceuticals Q4 Earningsbenzinga.com
Via Benzinga · February 23, 2026